<unk>  or<unk>  is an acronym for one of the chemotherapy regimens used in the treatment of relapsed or primary refractory non-Hodgkin's lymphoma and Hodgkin's lymphoma. When combined with Rituximab it is called R-GemOx, R-GEMOX or<unk> -R,<unk> -R. The R-GemOx regimen consists of: # (R)ituximab - anti-CD20 monoclonal antibody that has the ability to kill both normal and malignant B cells; # (Gem)citabine - an antimetabolite; # (Ox)aliplatin - a platinum-based alkylating antineoplastic agent.
GemOx
Normustine
Ifosfamide
Decitabine
Paclitaxel
FOLFOX
Estramustine phosphate
Etoposide